Combination Chemotherapy in Treating Patients With Colorectal Cancer
Study Information
Alliance Study ID: CALGB-9864
NCT Study ID (ClinicalTrials.gov): NCT00006103
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Brian Leyland-Jones, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if the effectiveness of irinotecan combined with fluorouracil in treating colorectal cancer varies depending on the patient’s racial background.
PURPOSE: Phase III trial to study the effectiveness of irinotecan combined with fluorouracil in treating patients from different racial backgrounds who have colorectal cancer that is advanced, recurrent, metastatic or has not responded to treatment with fluorouracil.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information